Status: Recruiting
AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
Children, adolescents, and young adults with malignant and non-malignant conditionsundergoing an allogeneic stem cell transplantation (AlloSCT) will have the stem cells selected utilizing α/β CD3+/CD19+ cell depletion. All other treatment is standard of care.
Participants needed: 20
Trial details
Phase: Phase 2Age: 1-30Biological sex: AllType: InterventionalSponsor: Mitchell CairoUpdated: Aug 8, 2025Locations: 1
Eligibility criteria
ALL:ALL high risk including one or more of the following: (t(9;22) or 11q23 chro... [+2]
Females who are pregnant or breast-feeding are not eligible. [+5]